• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用KCNU和Bmb6开发一种非酵母类开菲尔发酵乳。

A Non-yeast Kefir-like Fermented Milk Development with KCNU and Bmb6.

作者信息

Lee Bomee, Yong Cheng-Chung, Yi Hae-Chang, Kim Saehun, Oh Sejong

机构信息

Samik Dairy & Food Co. Ltd, Seoul 06195, Korea.

College of Life Sciences and Biotechnology, Korea University, Seoul 02841, Korea.

出版信息

Food Sci Anim Resour. 2020 Jul;40(4):541-550. doi: 10.5851/kosfa.2020.e31. Epub 2020 Jul 1.

DOI:10.5851/kosfa.2020.e31
PMID:32734262
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7372993/
Abstract

The use of yeast assist kefir fermentation, but also can cause food spoilage if uncontrolled. Hence, in this study, the microbial composition of an existing commercial kefir starter was modified to produce a functional starter, where KCNU and Bmb6 were used to replace yeast in the original starter to produce non-yeast kefir-like fermented milk. The functional starter containing KCNU and Bmb6 demonstrated excellent stability with 10 CFU/g of total viable cells throughout the 12 weeks low-temperature storage. The newly developed functional starter also displayed a similar fermentation efficacy as the yeast-containing control starter, by completing the milk fermentation within 12 h, with a comparable total number of viable cells (10 CFU/mL) in the final products, as in control. Sensory evaluation revealed that the functional starter-fermented milk highly resembled the flavor of the control kefir, with enhanced sourness. Furthermore, oral administration of functional starter-fermented milk significantly improved the disease activity index score by preventing drastic weight-loss and further deterioration of disease symptoms in DSS-induced mice. Altogether, KCNU and Bmb6 have successfully replaced yeast in a commercial starter pack to produce a kefir-like fermented milk beverage with additional health benefits. The outcome of this study provides an insight that the specific role of yeast in the fermentation process could be replaced with suitable probiotic candidates.

摘要

酵母可助力开菲尔发酵,但如果不受控制也会导致食物变质。因此,在本研究中,对现有的商业开菲尔发酵剂的微生物组成进行了改良,以生产一种功能性发酵剂,其中使用KCNU和Bmb6替代原始发酵剂中的酵母,从而生产出类似非酵母开菲尔的发酵乳。含有KCNU和Bmb6的功能性发酵剂在12周的低温储存期间,总活细胞数为10 CFU/g,表现出优异的稳定性。新开发的功能性发酵剂在12小时内完成牛奶发酵,最终产品中的活细胞总数(10 CFU/mL)与对照相当,其发酵效果与含酵母的对照发酵剂相似。感官评价显示,功能性发酵剂发酵的牛奶与对照开菲尔的风味高度相似,但酸度有所增强。此外,口服功能性发酵剂发酵的牛奶可显著提高疾病活动指数评分,防止DSS诱导的小鼠体重急剧下降和疾病症状进一步恶化。总之,KCNU和Bmb6已成功替代商业发酵剂包装中的酵母,生产出具有额外健康益处的类似开菲尔的发酵乳饮料。本研究结果表明,发酵过程中酵母的特定作用可以被合适的益生菌替代。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a20/7372993/620ae6c5ba32/kosfa-40-4-541-g4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a20/7372993/160c68160d16/kosfa-40-4-541-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a20/7372993/427d485a1115/kosfa-40-4-541-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a20/7372993/fe3198ad0c34/kosfa-40-4-541-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a20/7372993/620ae6c5ba32/kosfa-40-4-541-g4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a20/7372993/160c68160d16/kosfa-40-4-541-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a20/7372993/427d485a1115/kosfa-40-4-541-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a20/7372993/fe3198ad0c34/kosfa-40-4-541-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7a20/7372993/620ae6c5ba32/kosfa-40-4-541-g4.jpg

相似文献

1
A Non-yeast Kefir-like Fermented Milk Development with KCNU and Bmb6.利用KCNU和Bmb6开发一种非酵母类开菲尔发酵乳。
Food Sci Anim Resour. 2020 Jul;40(4):541-550. doi: 10.5851/kosfa.2020.e31. Epub 2020 Jul 1.
2
Chemical, Physiochemical, and Microstructural Properties, and Probiotic Survivability of Fermented Goat Milk Using Polymerized Whey Protein and Starter Culture Kefir Mild 01.使用聚合乳清蛋白和发酵剂开菲尔乳杆菌Mild 01发酵山羊奶的化学、物理化学和微观结构特性以及益生菌存活性
J Food Sci. 2017 Nov;82(11):2650-2658. doi: 10.1111/1750-3841.13935.
3
Effects of different fermentation parameters on quality characteristics of kefir.不同发酵参数对开菲尔品质特性的影响。
J Dairy Sci. 2013 Feb;96(2):780-9. doi: 10.3168/jds.2012-5753. Epub 2012 Dec 14.
4
Selection of lactic acid bacteria from Brazilian kefir grains for potential use as starter or probiotic cultures.从巴西开菲尔粒中筛选乳酸菌,以用作潜在的发酵剂或益生菌培养物。
Anaerobe. 2015 Apr;32:70-76. doi: 10.1016/j.anaerobe.2014.12.007. Epub 2014 Dec 24.
5
The effect of kefir produced from natural kefir grains on the intestinal microbial populations and antioxidant capacities of Balb/c mice.天然克菲尔粒发酵的克菲尔对 Balb/c 小鼠肠道微生物群和抗氧化能力的影响。
Food Res Int. 2019 Jan;115:408-413. doi: 10.1016/j.foodres.2018.10.080. Epub 2018 Oct 30.
6
Short communication: The effects of frozen storage on the survival of probiotic microorganisms found in traditionally and commercially manufactured kefir.简短通讯:冷冻储存对传统和商业生产的开菲尔中发现的益生菌微生物存活率的影响
J Dairy Sci. 2016 Sep;99(9):7043-7048. doi: 10.3168/jds.2015-10284. Epub 2016 Jun 8.
7
Physicochemical, microbiological and sensory profiles of fermented milk containing probiotic strains isolated from kefir.含益生菌菌株发酵乳的理化、微生物和感官特性,这些益生菌菌株是从开菲尔中分离出来的。
J Dairy Res. 2011 Nov;78(4):456-63. doi: 10.1017/S0022029911000653.
8
Sensory and Physicochemical Characterization of Sourdough Bread Prepared with a Coconut Water Kefir Starter.用椰子水开菲尔发酵剂制备的酸面团面包的感官和理化特性
Foods. 2020 Aug 24;9(9):1165. doi: 10.3390/foods9091165.
9
Kefir grains as a starter for whey fermentation at different temperatures: chemical and microbiological characterisation.不同温度下用克菲尔粒作为乳清发酵的起始剂:化学和微生物特性。
J Dairy Res. 2012 Aug;79(3):262-71. doi: 10.1017/S0022029912000179. Epub 2012 Apr 17.
10
Manufacturing of fermented goat milk with a mixed starter culture of Bifidobacterium animalis and Lactobacillus acidophilus in a controlled bioreactor.在可控生物反应器中用动物双歧杆菌和嗜酸乳杆菌混合发酵剂生产发酵山羊奶。
Lett Appl Microbiol. 2006 Jun;42(6):595-9. doi: 10.1111/j.1472-765X.2006.01882.x.

引用本文的文献

1
Regulatory Effect of Bmb6 on Gut Barrier Functions in Experimental Colitis.Bmb6对实验性结肠炎肠道屏障功能的调节作用
Foods. 2020 Jul 2;9(7):864. doi: 10.3390/foods9070864.

本文引用的文献

1
Short communication: The effects of frozen storage on the survival of probiotic microorganisms found in traditionally and commercially manufactured kefir.简短通讯:冷冻储存对传统和商业生产的开菲尔中发现的益生菌微生物存活率的影响
J Dairy Sci. 2016 Sep;99(9):7043-7048. doi: 10.3168/jds.2015-10284. Epub 2016 Jun 8.
2
Evaluation of wound healing activities of kefir products.评价克菲尔产品的伤口愈合活性。
Burns. 2012 Aug;38(5):719-23. doi: 10.1016/j.burns.2011.12.005. Epub 2012 Jan 10.
3
Study of immune cells involved in the antitumor effect of kefir in a murine breast cancer model.
在小鼠乳腺癌模型中对开菲尔抗肿瘤作用所涉及的免疫细胞的研究。
J Dairy Sci. 2007 Apr;90(4):1920-8. doi: 10.3168/jds.2006-079.
4
Kefir: a symbiotic yeasts-bacteria community with alleged healthy capabilities.开菲尔:一种据称具有有益健康功效的共生酵母-细菌群落。
Rev Iberoam Micol. 2006 Jun;23(2):67-74. doi: 10.1016/s1130-1406(06)70016-x.
5
Hypocholesterolaemic effects of milk-kefir and soyamilk-kefir in cholesterol-fed hamsters.牛奶开菲尔和豆奶开菲尔对高胆固醇喂养仓鼠的降胆固醇作用。
Br J Nutr. 2006 May;95(5):939-46. doi: 10.1079/bjn20061752.
6
Probiotic effects of Lactobacillus casei on DSS-induced ulcerative colitis in mice.干酪乳杆菌对葡聚糖硫酸钠诱导的小鼠溃疡性结肠炎的益生菌作用。
Int J Food Microbiol. 2005 Aug 25;103(2):143-55. doi: 10.1016/j.ijfoodmicro.2004.11.032.
7
Antimutagenic and antioxidant properties of milk-kefir and soymilk-kefir.牛奶开菲尔和豆奶开菲尔的抗诱变和抗氧化特性。
J Agric Food Chem. 2005 Apr 6;53(7):2467-74. doi: 10.1021/jf048934k.
8
A synergism between yoghurt bacteria and yeasts and the effect of their association upon the viability of the bacteria.酸奶细菌与酵母之间的协同作用及其联合对细菌生存能力的影响。
Appl Microbiol. 1955 May;3(3):129-31. doi: 10.1128/am.3.3.129-131.1955.
9
The protective effect of fermented milk kefir on radiation-induced apoptosis in colonic crypt cells of rats.发酵乳开菲尔对大鼠结肠隐窝细胞辐射诱导凋亡的保护作用。
J Radiat Res. 2003 Jun;44(2):111-5. doi: 10.1269/jrr.44.111.
10
Kefir improves lactose digestion and tolerance in adults with lactose maldigestion.开菲尔可改善乳糖消化不良成年人的乳糖消化及耐受性。
J Am Diet Assoc. 2003 May;103(5):582-7. doi: 10.1053/jada.2003.50111.